Glen Eagle Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62K Buy
204
+95
+87% +$2.13K ﹤0.01% 804
2026
Q1
$2.47K Hold
109
﹤0.01% 826
2025
Q4
$2.6K Hold
109
﹤0.01% 851
2025
Q3
$2.88K Hold
109
﹤0.01% 854
2025
Q2
$3.12K Buy
109
+2
+2% +$54 ﹤0.01% 796
2025
Q1
$2.67K Hold
107
﹤0.01% 813
2024
Q4
$2.43K Hold
107
﹤0.01% 848
2024
Q3
$2.28K Hold
107
﹤0.01% 889
2024
Q2
$2.05K Buy
+107
New +$2.18K ﹤0.01% 900

Other funds holding FMS

Glen Eagle Advisors's FMS Position: Q2 2026 in Review

Glen Eagle Advisors increased its Fresenius Medical Care (FMS) stake by 87% in Q2 2026, buying an estimated $2.13K and bringing the position to 204 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #804.

Glen Eagle Advisors first reported a position in FMS in Q2 2024 and has held it in 9 quarters since. 235 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Glen Eagle Advisors held 204 shares of Fresenius Medical Care worth $4.62K as of Q2 2026.
  • Glen Eagle Advisors bought 95 Fresenius Medical Care shares in Q2 2026, an estimated $2.13K.
  • Fresenius Medical Care made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #804 holding.
  • Glen Eagle Advisors first reported a position in Fresenius Medical Care in Q2 2024 and has held it in 9 quarters since.
  • 235 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.